Intent.Health Supplier Deep View: How Healthcare Suppliers Move Innovation to Care
The Healthcare Value Chain
How innovation physically and financially moves to the patient.
1. Manufacturer
Pharma, MedTech, Biotech
- R&D & Clinical Trials
- Regulatory Approval (FDA)
- Market Access Strategy
2. Intermediary
Wholesalers, GPOs, PBMs
- Contract Negotiation (GPO)
- Logistics & Distribution
- Formulary Management (PBM)
3. Provider
Hospitals, Clinics, Pharmacies
- Procurement & Inventory
- Prescribing & Usage
- Patient Administration
4. End User
Patients & Payers
- Consumption / Outcomes
- Reimbursement
- Copay & Deductibles
Intent Insight: You cannot sell directly to a hospital without navigating the Intermediary Layer (GPOs for MedTech, Wholesalers for Pharma).
The Supplier Micro-Ecosystems
Pharmaceuticals
Driven by R&D cliffs and patent life. Distribution flows through the "Big 3" wholesalers (McKesson, Cardinal, AmerisourceBergen). Sales target Prescribers, but access is controlled by PBM Formularies.
Pfizer, Merck, J&J, AbbVie
Medical Devices
Ranges from consumables (gloves) to capital (MRI). Heavy reliance on GPO contracts for access. Sales involve Value Analysis Committees (VAC) and clinical champions.
Medtronic, Stryker, GE HealthCare
Healthcare IT
EHRs, RCM, and Telehealth. The challenge is interoperability and workflow integration. Sales target the CIO and CMIO. Security (HIPAA) is the primary blocker.
Epic, Oracle Health, Change Healthcare
The Retail View
Pharmacies, DME (Durable Medical Equipment), and Home Health supplies. Moving towards direct-to-consumer and "health hub" models.
CVS, Walgreens, Apria, Amazon
The "Valley of Death"
The rigorous path from idea to market access.
Funding & R&D
Angel & VC Capital: Funding high-risk innovation. Most startups fail here.
Key Insight: Investment must be aligned with a clear exit strategy (acquisition by a major supplier).
Regulatory Clearance (FDA)
The Gatekeeper: Determining safety and efficacy.
Pathways: 510(k) (Substantial Equivalence) vs. PMA (Pre-Market Approval: Rigorous).
Reimbursement Coding
Getting Paid: Even if approved, if there is no CPT/DRG code, providers won't buy it. You must secure coverage from CMS and Private Payers.
Market Access & Sales
The Final Mile: Getting on GPO contracts, passing VAC reviews, and driving utilization with clinicians.
